Detailed answers about CIO CLINICAL RESEARCH CONSULTANCY LIMITED, including incorporation, status, business activity, and accounts information.
When was CIO CLINICAL RESEARCH CONSULTANCY LIMITED founded?
CIO CLINICAL RESEARCH CONSULTANCY LIMITED was officially incorporated on 16 May 2022 and is registered under company number 14109243. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CIO CLINICAL RESEARCH CONSULTANCY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CIO CLINICAL RESEARCH CONSULTANCY LIMITED?
CIO CLINICAL RESEARCH CONSULTANCY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CIO CLINICAL RESEARCH CONSULTANCY LIMITED do?
CIO CLINICAL RESEARCH CONSULTANCY LIMITED operates in the following sectors: 70229 - Management consultancy activities other than financial management, 74909 - Other professional, scientific and technical activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is CIO CLINICAL RESEARCH CONSULTANCY LIMITED's registered address?
The registered office address of CIO CLINICAL RESEARCH CONSULTANCY LIMITED is 138 MOTTISFONT ROAD, LONDON, ENGLAND, SE2 9LW. This is the official address filed with Companies House for legal and statutory correspondence.
Is CIO CLINICAL RESEARCH CONSULTANCY LIMITED financially stable?
The most recent accounts for CIO CLINICAL RESEARCH CONSULTANCY LIMITED were made up to 31 May 2024, filed as MICRO ENTITY. Next accounts are due by 31 May 2026.